Alternative Models for Anticancer Drug Discovery From Natural Products Using Binary Tumor‐Microenvironment‐on‐a‐Chip
Advanced Science · 2025-10 · 12 (40)
DOI: 10.1002/advs.202507944 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 28.07.2025. Verfasst von Youngwon Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Mechanical Engineering, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul, 13722, Republic of Korea. Hauptthemen laut MEDLINE: Tumor Microenvironment, Biological Products, Antineoplastic Agents, Drug Discovery. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Ministry of Environment (MOE), Ministry of Science, ICT and Future Planning.
Abstract (Originalsprache)
The efficacy evaluation of anticancer drugs derived from natural products has traditionally relied on animal models, highlighting the need for more efficient preclinical assessment platforms. In this study, a binary tumor‐microenvironment‐on‐a‐chip (T‐MOC) system is introduced to assess the therapeutic potential of illudin S and roridin E, two cytotoxic compounds derived from Omphalotus japonicus and Podostroma cornu‐damae , respectively. The binary T‐MOC model integrates independently developed vascular and invasive ductal carcinoma compartments, effectively mimicking in vivo drug delivery barriers and physiological dynamics. Using this model, illudin S demonstrates strong anticancer effects but exhibits high toxicity, particularly in the lung and liver, indicating a narrow therapeutic window. Roridin E demonstrates potent activity at low concentrations but exhibits high toxicity, especially in the liver and skin. Additionally, morphological analysis is performed to predict drug delivery and distribution characteristics, revealing anisotropic remission and the influence of microenvironmental factors on drug response. This study underscores the potential of the binary T‐MOC system as an alternative platform for anticancer drug evaluation, enabling efficient preclinical validation while reducing reliance on animal models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Mechanical Engineering, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul, 13722, Republic of Korea.
- College of Medicine, Dongguk University, 32 Dongguk-ro, Ilsandong-gu, Goyangsi, Gyeonggi-do, 10326, Republic of Korea.
- School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
- College of Korean Medicine, Gachon University, Seongnam, 13120, Republic of Korea.
- School of Mechanical Engineering, Yeungnam University, 280 Daehak-ro, Gyeongsan-si, Gyeongsangbuk-do, 38541, Republic of Korea.
- MediSphere Inc., 280, Daehak-ro, Gyeongsan-si, Gyeongsangbuk-do, 38541, Republic of Korea.
ORCID-Profile: Bongseop Kwak
Förderung
- Korea Ministry of Environment (MOE)
- Ministry of Science, ICT and Future Planning
Zitieren
APA
Kim, Y., Chae, S. H., Lee, D., Lee, B. S., Lim, J., Jung, H. I., Kim, K. H., & Kwak, B. (2025). Alternative Models for Anticancer Drug Discovery From Natural Products Using Binary Tumor‐Microenvironment‐on‐a‐Chip. Advanced Science, 12(40). https://doi.org/10.1002/advs.202507944
Vancouver
Kim Y, Chae SH, Lee D, Lee BS, Lim J, Jung HI, et al. Alternative Models for Anticancer Drug Discovery From Natural Products Using Binary Tumor‐Microenvironment‐on‐a‐Chip. Advanced Science. 2025;12(40). doi:10.1002/advs.202507944
BibTeX
@article{Kim2025,
author = {Kim, Youngwon and Chae, Si Hyeon and Lee, Dahae and Lee, Bum Soo and Lim, Jiseok and Jung, Hyo-Il and Kim, Ki Hyun and Kwak, Bongseop},
title = {Alternative Models for Anticancer Drug Discovery From Natural Products Using Binary Tumor‐Microenvironment‐on‐a‐Chip},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {40},
doi = {10.1002/advs.202507944}
}
EUVIMED